Could toxoplasma gondii have any role in alzheimer disease?

Alzheimer Disease and Associated Disorders

Volumn 25, Issue 1, 2011, Pages 1-3

  Kusbeci, Ozge Yilmaz ^a   Miman, Ozlem ^a   Yaman, Mehmet ^a   Aktepe, Orhan Cem ^a   Yazar, Suleyman ^b  

^a AFYON KOCATEPE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Alzheimer disease; neurodegeneration; neuroinflammation; Toxoplasma gondii; toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

AGED; ALZHEIMER DISEASE; ANTIBODY BLOOD LEVEL; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; TOXOPLASMA GONDII; TOXOPLASMOSIS;

AGED; ALZHEIMER DISEASE; ANTIBODIES, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; TOXOPLASMOSIS;

EID: 79952185659     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3181f73bc2     Document Type: Article

References (30)

1. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239-259.
2. Felician O, Sandson TA. The neurobiology and pharma-cotherapy of Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1999;11:19-31.
3. Van Hoesen GW, Augustinack JC, Dierking J, et al. The parahippocampal gyrus in Alzheimer's disease: clinical and preclinical ne (Pubitemid 30462087)
4. Glass CK, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918-934.
5. Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 2009;8:382-397.
6. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci. 2004;1035:104-116. (Pubitemid 40362329)
7. Halonen SK, Lyman WD, Chiu FC. Growth and development of Toxoplasma gondii in human neurons and astrocytes. J Neuropathol Exp Neurol. 1996;55:1150-1156. (Pubitemid 26372792)
8. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363: 1965-1976. (Pubitemid 38759657)
9. Koseoglu E, Yazar S, Koc I. Is Toxoplasma gondii a causal agent in migraine? Am J Med Sci. 2009;338:120-122.
10. Miman O, Mutlu EA, Ozcan O, et al. Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Psychiatry Res. 2010. [Epub ahead of print]
11. Torrey EF, Bartko JJ, Lun ZR, et al. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull. 2007;33:729-736. (Pubitemid 47343710)
12. Yazar S, Arman F, Yalçn S, et al. Investigation of probable relationship between Toxoplasma gondii and cryptogenic epilepsy. Seizure. 2003;12:107-109. (Pubitemid 36284984)
13. Henriquez SA, Brett R, Alexander J, et al. Neuropsychiatric Disease and Toxoplasma gondii infection. Neuroimmunomodulation. 2009;16:122-133.
14. Tamer SG, Dundar D, Yalug I, et al. The schizophrenia and Toxoplasma gondii connection: infectious, immune or both? Adv Ther. 2008;25:703-709.
15. Hermes G, Ajioka JW, Kelly KA, et al. Neurological and behavioral abnormalities, ventricular dilatation, altered cellu-lar functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation. 2008;5:48.
16. Rozenfeld C, Martinez R, Seabra S, et al. Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia. Am J Pathol. 2005;167:1021-1031. (Pubitemid 41416254)
17. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944. (Pubitemid 14076461)
18. Havlicek J, Gasova Z, Smith AP, et al. Decrease of psychomotor performance in subjects with latent 'asympto-matic' toxoplasmosis. Parasitology. 2001;122:515-520. (Pubitemid 32531309)
19. Cetinkaya Z, Yazar S, Gecici O, et al. Anti-Toxoplasma gondii antibodies in patients with schizophrenia: preliminary findings in a Turkish sample. Schizophr Bull. 2007;33:789-791. (Pubitemid 47343723)
20. Holmes C, Cotterell D. Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs. 2009;23:993-1002.
21. Honjo K, van Reekum R, Verhoeff NP. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement. 2009;5:348-360.
22. Garcia SL. Tissue Protozoa (Toxoplasma gondii). In: Garcia SL, ed. Diagnostic Medical Parasitology. 4th ed. Washington, DC: American Society for Microbiology; 2001:132-142.
23. Creuzet C, Robert F, Roisin MP, et al. Neurons in primary culture are less efficiently infected by Toxoplasma gondii than glial cells. Parasitol Res. 1998;84:25-30. (Pubitemid 28097621)
24. Nath A, Sinai AP. Cerebral Toxoplasmosis. Curr Treat Options Neurol. 2003;5:3-12.
25. Chao CC, Anderson WR, Hu S, et al. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin Immunol Immunopathol. 1993;67:178-183. (Pubitemid 23144455)
26. Carruthers VB, Suzuki Y. Effects of Toxoplasma gondii infection on the brain. Schizophr Bull. 2007;33:745-751. (Pubitemid 47343715)
27. Suzuki Y, Orellana MA, Schreiber RD, et al. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988;240:516-518.
28. Kang H, Suzuki Y. Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain. Infect Immun. 2001;69:2920-2927. (Pubitemid 32332183)
29. Kim YS, Joh TH. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp Mol Med. 2006;38:333-347.
30. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21:383-421. (Pubitemid 30349107)